tiprankstipranks
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market

Edgewise Therapeutics (EWTX) Financial Statements

100 Followers

Edgewise Therapeutics Financial Overview

Edgewise Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.57; its P/E ratio is -11.44; Edgewise Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -30.14M$ -25.71M$ -21.47M$ -25.70M-
EBITDA$ -31.77M--$ -27.53M-
Net Income Common Stockholders$ -30.14M$ -25.71M$ -21.47M$ -22.84M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 318.39M$ 289.70M$ 309.93M$ 327.95M$ 351.95M
Total Assets$ 340.04M$ 311.36M$ 330.63M$ 346.40M$ 367.10M
Total Debt$ 5.41M$ 5.53M$ 5.64M$ 5.64M$ 4.41M
Net Debt$ -312.98M$ -284.17M$ -304.29M$ -322.31M$ -347.54M
Total Liabilities$ 21.20M$ 20.94M$ 19.17M$ 17.56M$ 20.39M
Stockholders Equity$ 318.83M$ 290.43M$ 311.46M$ 328.84M$ 346.72M
Cash Flow-
Free Cash Flow$ -26.99M--$ -27.19M$ -15.10M
Operating Cash Flow$ -26.83M$ -22.06M-$ -22.82M-
Investing Cash Flow$ 26.98M$ 23.42M-$ 49.04M-
Financing Cash Flow$ 52.99M$ -211.00K-$ 21.00K-
Currency in USD

Edgewise Therapeutics Earnings and Revenue History

Edgewise Therapeutics Debt to Assets

Edgewise Therapeutics Cash Flow

Edgewise Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis